Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Effects of rivaroxaban combined with clopidogrel on thrombotic risk and myocardial injury indicators in patients with coronary artery ectasia.

Objective To investigate the association between rivaroxaban combined with clopidogrel therapy and thrombotic risk, platelet activation, myocardial injury biomarkers, and clinical outcomes in patients with coronary artery ectasia (CAE). Methods This single-center retrospective cohort study included 158 consecutive pa...

Tao Geng, Meng Feng, Yun-Jie Wu et al. · 0 citations
Aug 2026

LncRNA NONMMUT051252 promotes atopic dermatitis via the miR-141-5p/USP14/cGAS-STING axis and ferroptosis.

These findings identify a previously unrecognized lncRNA 051252/miR-141-5p/USP14/cGAS-STING signaling axis that drives inflammatory responses and ferroptosis in AD, providing new mechanistic insights into disease pathogenesis and highlighting potential therapeutic targets.

Yue Du, Shan Jin, Ke-Xin Xu et al. · 1 citation
Open access Jul 2026

Rivaroxaban plus antiplatelet therapy for coronary artery ectasia: 36-month outcomes and risk prediction from a retrospective cohort study

In patients with CAE, low-dose rivaroxaban combined with single antiplatelet therapy was associated with lower long-term MACE risk without a significant increase in major bleeding.

Meng Feng, Yun-Jie Wu, Chaoqing Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.